These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28612733)

  • 21. CRISPR fixes disease gene in viable human embryos.
    Ledford H
    Nature; 2017 Aug; 548(7665):13-14. PubMed ID: 28770860
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insertional Mutagenesis by CRISPR/Cas9 Ribonucleoprotein Gene Editing in Cells Targeted for Point Mutation Repair Directed by Short Single-Stranded DNA Oligonucleotides.
    Rivera-Torres N; Banas K; Bialk P; Bloh KM; Kmiec EB
    PLoS One; 2017; 12(1):e0169350. PubMed ID: 28052104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiplex conditional mutagenesis in zebrafish using the CRISPR/Cas system.
    Yin L; Maddison LA; Chen W
    Methods Cell Biol; 2016; 135():3-17. PubMed ID: 27443918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromatin accessibility and guide sequence secondary structure affect CRISPR-Cas9 gene editing efficiency.
    Jensen KT; Fløe L; Petersen TS; Huang J; Xu F; Bolund L; Luo Y; Lin L
    FEBS Lett; 2017 Jul; 591(13):1892-1901. PubMed ID: 28580607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The First Chinese Edited Babies: A Leap of Faith in Science.
    Raposo VL
    JBRA Assist Reprod; 2019 Aug; 23(3):197-199. PubMed ID: 31436399
    [No Abstract]   [Full Text] [Related]  

  • 27. Multiple site-directed mutagenesis via simple cloning by prolonged overlap extension.
    Hejlesen R; Füchtbauer EM
    Biotechniques; 2020 Jun; 68(6):345-348. PubMed ID: 32372650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR/Cas9: an advanced tool for editing plant genomes.
    Samanta MK; Dey A; Gayen S
    Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies.
    Wang G; Yang L; Grishin D; Rios X; Ye LY; Hu Y; Li K; Zhang D; Church GM; Pu WT
    Nat Protoc; 2017 Jan; 12(1):88-103. PubMed ID: 27929521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FDA Regulation of Clinical Applications of CRISPR-CAS Gene-Editing Technology.
    Grant EV
    Food Drug Law J; 2016; 71(4):608-33. PubMed ID: 29140647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
    Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ
    J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Transgenic Core Facility's Experience in Genome Editing Revolution.
    Yuan CL; Hu YC
    Adv Exp Med Biol; 2017; 1016():75-90. PubMed ID: 29130154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene editing using CRISPR-Cas9 for the treatment of lung cancer.
    Castillo A
    Colomb Med (Cali); 2016 Dec; 47(4):178-180. PubMed ID: 28293040
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish.
    Hruscha A; Krawitz P; Rechenberg A; Heinrich V; Hecht J; Haass C; Schmid B
    Development; 2013 Dec; 140(24):4982-7. PubMed ID: 24257628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR/Cas9-mediated correction of human genetic disease.
    Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
    Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR/Cas9 technology: applications in oocytes and early embryos.
    Zhang YR; Yin TL; Zhou LQ
    J Transl Med; 2023 Oct; 21(1):746. PubMed ID: 37875936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Introducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editing.
    Kang X; He W; Huang Y; Yu Q; Chen Y; Gao X; Sun X; Fan Y
    J Assist Reprod Genet; 2016 May; 33(5):581-588. PubMed ID: 27052831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the potential of genome editing CRISPR-Cas9 technology.
    Singh V; Braddick D; Dhar PK
    Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The tsunami named CRISPR/Cas9.
    Chneiweiss H
    Rev Neurol (Paris); 2018; 174(7-8):487-488. PubMed ID: 29779853
    [No Abstract]   [Full Text] [Related]  

  • 40. The application of CRISPR/Cas9 in genome editing of filamentous fungi.
    Li HH; Liu G
    Yi Chuan; 2017 May; 39(5):355-367. PubMed ID: 28487268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.